SSRI Labels to be Updated

In a move that will be at least of interest to litigation over suicidality and anti-depressants, the FDA has directed (FDA press release) makers of SSRIs to modify the black box warning about suicidality among young users of the drugs.  The FDA has a page about anti-depressants, including the proposed new labeling.